Coagulopathy and inhospital deaths in patients with acute subdural hematoma

被引:38
作者
Bershad, Eric M. [1 ,2 ]
Farhadi, Saeid [3 ]
Suri, M. Fareed K. [4 ]
Feen, Eliahu S. [5 ]
Hernandez, Olga H. [6 ]
Selman, Warren R. [3 ]
Suarez, Jose I. [1 ,2 ]
机构
[1] Baylor Coll Med, Dept Neurol, Div Vasc Neurol & Neurocrit Care, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Neurosurg, Div Vasc Neurol & Neurocrit Care, Houston, TX 77030 USA
[3] Univ Hosp Case Med Ctr, Dept Neurosurg, Neurol Inst, Cleveland, OH USA
[4] Univ Minnesota, Dept Neurol, Minneapolis, MN USA
[5] St Louis Univ, Dept Neurol, Div Neurocrit Care, St Louis, MO 63103 USA
[6] Inst Neurol Antioquia, Div Neurocrit Care, Medellin, Colombia
关键词
acute subdural hematoma; coagulopathy; inhospital death; outcome;
D O I
10.3171/JNS/2008/109/10/0664
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Acute subdural hematoma (SDH) is one of the most lethal forms of intracranial injury; several risk factors predictive of a worse Outcome have been identified. Emerging research suggests that patients with coagulopathy and intracerebral hemorrhage have a worse outcome than patients without coagulopathy but with intracerebral hemorrhage. The authors sought to determine if such a relationship exists for patients with acute SDH. Methods. The authors conducted a retrospective analysis of consecutive patients admitted to a neurosciences intensive care unit with acute SDH over a 4-year period (January 1997-December 2001). Demographic data, laboratory Values, admission source. prior functional status. medical comorbidities, treatments received, and discharge disposition were recorded, as were scores oil the Acute Physiology, Age, and Chronic Health Evaluation III (APACHE 111). Coagulopathy was defined as all internal normalized ratio > 1.2 or a prothrombin time >= 12.7 seconds. Univariate and multivariate analyses were performed on 244 patients to determine factors associated with worse short-term outcomes. Results. The authors identified 248 patients with acute SDH admitted to the neurointensive care unit during the study period, of which 244 had complete data. Most were male (61%). and the mean age of the Study Population was 71.3 +/- 15 years (range 20-95 years). Fifty-three patients (22%) had coagulopathy. The median APACHE III score was 43 (range 11-119). Twenty-nine patients (12%) died in the hospital. Independent predictors of inhospital death included APACHE III score (odds ratio [OR] 4.4, 95% confidence interval [CI] 1.4-13.4. p = 0.011) and coagulopathy (OR 2.7, 95% CI 1.1-7.1. p = 0.037). Surgical evacuation Of acute SDH was associated with reduced inhospital deaths (OR 0.2, 95% CI 0.1-0.6, p = 0.003). Conclusions. Coagulopathy is independently associated with inhospital death in patients with acute SDH. Time to treatment to correct coagulopathy using fresh frozen plasma and/or vitamin K was prolonged.
引用
收藏
页码:664 / 669
页数:6
相关论文
共 23 条
[1]   Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].
Abraham, E ;
Reinhart, K ;
Opal, S ;
Demeyer, I ;
Doig, C ;
Rodriguez, AL ;
Beale, R ;
Svoboda, P ;
Laterre, PF ;
Simon, S ;
Light, B ;
Spapen, H ;
Stone, J ;
Seibert, A ;
Peckelsen, C ;
De Deyne, C ;
Postier, R ;
Pettilä, V ;
Sprung, CL ;
Artigas, A ;
Percell, SR ;
Shu, V ;
Zwingelstein, C ;
Tobias, J ;
Poole, L ;
Stolzenbach, JC ;
Creasey, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247
[2]   VOLUME OF INTRACEREBRAL HEMORRHAGE - A POWERFUL AND EASY-TO-USE PREDICTOR OF 30-DAY MORTALITY [J].
BRODERICK, JP ;
BROTT, TG ;
DULDNER, JE ;
TOMSICK, T ;
HUSTER, G .
STROKE, 1993, 24 (07) :987-993
[3]   Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage [J].
Brody, DL ;
Aiyagari, V ;
Shackleford, AM ;
Diringer, MN .
NEUROCRITICAL CARE, 2005, 2 (03) :263-267
[4]   A clinical comparison of non-traumatic acute subdural haematomas either related to coagulopathy or of arterial origin without coagulopathy [J].
Depreitere, B ;
Van Calenbergh, F ;
van Loon, J .
ACTA NEUROCHIRURGICA, 2003, 145 (07) :541-546
[5]   Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation [J].
Dickneite, Gerhard .
THROMBOSIS RESEARCH, 2007, 119 (05) :643-651
[6]   Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage [J].
Flibotte, JJ ;
Hagan, N ;
O'Donnell, J ;
Greenberg, SM ;
Rosand, J .
NEUROLOGY, 2004, 63 (06) :1059-1064
[7]   Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage [J].
Goldstein, JN ;
Thomas, SH ;
Frontiero, V ;
Joseph, A ;
Engel, C ;
Snider, R ;
Smith, EE ;
Greenberg, SM ;
Rosand, J .
STROKE, 2006, 37 (01) :151-155
[8]   The ICH score - A simple, reliable grading scale for intracerebral hemorrhage [J].
Hemphill, JC ;
Bonovich, DC ;
Besmertis, L ;
Manley, GT ;
Johnston, SC .
STROKE, 2001, 32 (04) :891-896
[9]   Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial [J].
Kennedy, James ;
Hill, Michael D. ;
Ryckborst, Karla J. ;
Eliasziw, Michael ;
Demchuk, Andrew M. ;
Buchan, Alastair M. .
LANCET NEUROLOGY, 2007, 6 (11) :961-969
[10]   Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-based data? [J].
Kessler, CM .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (05) :963-966